Indegene
INDGN · > Business Support Listing date: May 13, 2024

Stock Price vs Company Growth
1d
1.0%
1w
0.1%
1m
11.9%
3m
10.9%
6m
14.6%
1y
3.0%
all
0.1%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 568 1.0%
480
584
Company Overview

Sales
3,813 Cr
Growth: 22.0%
Profit after Tax
401 Cr
Growth: -0.0%
Mid Cap
13,683 Cr
P/E: 34.2x
Industry P/E: 20.0x
Fundamentals

Sales (Cr) ₹ 3,813
Growth 22.0%
EBITDA 16.7%
P/S 3.6x
Dividend 0.3%
P/E 34.2x
Book Value ₹ 135
PEG Ratio 1.5x
ROE 13.2%
P/B 4.1x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company offers solutions straddling the different stages of the commercialization lifecycle of drugs and medical devices. It caters to the commercial function needs of life sciences companies through its Enterprise Commercial Solutions and its Omnichannel Activation Solutions. For the medical and R&D function needs, it operates through its Enterprise Medical Solutions and Enterprise Clinical Solutions.
Investors (4)
Followers (1)